MEN Type 2, or Multiple Endocrine Neoplasia Type 2, is a genetic disorder that affects the endocrine system, leading to the development of tumors in multiple glands. It is primarily associated with three types of tumors: medullary thyroid carcinoma, pheochromocytoma, and primary hyperparathyroidism. These tumors can cause various hormonal imbalances and health issues. This condition is caused by mutations in the RET gene, which plays a crucial role in cell signaling and growth. Individuals with MEN Type 2 often require regular monitoring and may need surgical interventions to manage the tumors and prevent complications. Early diagnosis and treatment are essential for better outcomes.